Physician profile
Rocio Ahuja
NPI 1699057976
$11,316.82
in general payments reported to CMS, 2019-2025
28 companies · $1,200 in 2025
The $1,200 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $322 · 2021: $7,128 · 2022: $1,318 · 2023: $630 · 2024: $272 · 2025: $1,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,102.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,137.57 | 2021-2023 | |
| Esperion Therapeutics, INC. | $704.96 | 2021-2022 | |
| Amgen INC. | $641.12 | 2019-2025 | Otezla, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $424.40 | 2022-2025 | |
| Lilly USA, LLC | $357.78 | 2019-2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $342.80 | 2022-2025 | Ozempic |
| Insulet Corporation | $279.00 | 2020-2025 | Omnipod |
| Glaxosmithkline, LLC. | $200.88 | 2023 | Shingrix, Arexvy |
| Allergan, INC. | $175.46 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $162.35 | 2022 | |
| Astellas Pharma US INC | $145.28 | 2023 | Veozah |
| Lundbeck LLC | $124.07 | 2025 | Vyepti |
| Astrazeneca Pharmaceuticals Lp | $121.12 | 2025 | Breztri |
| Abbvie INC. | $115.70 | 2019 | |
| Pfizer INC. | $87.45 | 2023-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $48.05 | 2025 | Nexplanon, Nuvaring |
| Mayne Pharma Commercial LLC | $47.57 | 2025 | |
| Coopersurgical, INC. | $32.89 | 2019 | |
| Becton, Dickinson and Company | $27.41 | 2019 | |
| Biogen, INC. | $23.04 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $18.36 | 2020 | |
| Medline Industries Lp | $17.41 | 2020 | |
| Dexcom, INC. | $16.37 | 2024 | Dexcom G6 Transmitter |
| Ethicon US, LLC | $15.18 | 2019 | |
| Lupin INC. | $14.57 | 2019 | |
| Therapeuticsmd, INC. | $12.13 | 2019 | |
| Xeris Pharmaceuticals, INC. | $12.08 | 2022 | |
| Alexion Pharmaceuticals, INC. | $11.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rocio Ahuja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.